Mattel Inc vs Sana Biotechnology Inc — how do they compare? Mattel Inc trades at $14.19 (market cap $4.11B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Mattel Inc is far larger — about 4.7× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| MAT | SANA | |
|---|---|---|
Market Cap | $4.11B | $873.84M |
Sector | Consumer Cyclical | Health |
52-Week High | $22.16 | $5.92 |
52-Week Low | $13.05 | $2.68 |
Enterprise Value | $5.92B | $848.03M |
Trailing returns across standard periods
Latest headlines on both assets
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →